Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03841565 |
|---|---|
| Brief Title: | Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma |
| First Submitted : | February 13, 2019 |
| First Submitted that Met QC Criteria : | February 13, 2019 |
| First Posted : | February 15, 2019 |
| Last Update Submitted that Met QC Criteria : | June 13, 2022 |
| Last Update Posted : | June 15, 2022 |